The branching of glycolytic metabolites to anabolic pathways such as amino acid or nucleotide synthesis and the regulation of mitochondrial metabolism are important processes in tumor development, and NRF2 has been shown to control key enzymes in these pathways. This evidence concerns the gene NFE2L2 and neoplasm.